Literature DB >> 7109356

The effectiveness of wide anatomical resection and radical lymphadenectomy for patients with rectal cancer.

K Hojo, Y Koyama.   

Abstract

The results of wide anatomical resection and radical lymphadenectomy which we termed the extended operation were examined. Materials consisted of 160 Japanese patients who underwent conventional operation during 1962-1968 prior to the introduction of extended operation, 113 patients who underwent extended operation since 1969, and 119 patients who underwent conventional operation from 1969 to 1976. The cumulative 5-year survival rates were 70% (1962-1968) and 67.8% (1969-1976) for the conventional operation groups and 90.3% for the extended operation group in Dukes B group (p less than 0.05). In Dukes C group, the rates were 26.3% (1962-1968) and 37.8% (1969-1976) for the conventional operation groups and 51.6% for the extended operation group. The incidences of local recurrence in Dukes B group were 25% (1969-1976) in the conventional operation group and 6.5% in the extended operation group, while in Dukes C group the rates were 45.0% (1969-1976) and 25% respectively. Our study demonstrated that the extended operation resulted in a decrease in the local recurrence of rectal cancer and prognosis. We therefore recommend that extensive surgery be planned for advanced cases of rectal cancer.

Entities:  

Mesh:

Year:  1982        PMID: 7109356     DOI: 10.1007/BF02469377

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  2 in total

1.  Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum.

Authors:  M W STEARNS; M R DEDDISH
Journal:  Dis Colon Rectum       Date:  1959 Mar-Apr       Impact factor: 4.585

2.  Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection.

Authors:  W E Enker; U T Laffer; G E Block
Journal:  Ann Surg       Date:  1979-09       Impact factor: 12.969

  2 in total
  12 in total

Review 1.  Chemoradiotherapy and adjuvant chemotherapy for rectal cancer.

Authors:  Toshiaki Watanabe
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

2.  Prevention and management of recurrent rectal cancer.

Authors:  R W Beart
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

3.  Lateral lymph node dissection for lower rectal cancer.

Authors:  T Nakamura; M Watanabe
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

4.  Adjuvant treatment in colorectal cancer: an update.

Authors:  H O Douglass
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

5.  Can radical surgery improve survival in colorectal cancer?

Authors:  J Jeekel
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

6.  Preoperative chemoradiation and extended pelvic lymphadenectomy for rectal cancer: Two distinct principles.

Authors:  Tsuyoshi Konishi; Toshiaki Watanabe; Hirokazu Nagawa; Masatoshi Oya; Masashi Ueno; Hiroya Kuroyanagi; Yoshiya Fujimoto; Takashi Akiyoshi; Toshiharu Yamaguchi; Tetsuichiro Muto
Journal:  World J Gastrointest Surg       Date:  2010-04-27

7.  Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle to lower rectal cancers.

Authors:  K Koda; N Saito; K Oda; N Takiguchi; H Sarashina; M Miyazaki
Journal:  Int J Colorectal Dis       Date:  2003-11-22       Impact factor: 2.571

Review 8.  Results of radical surgery for rectal cancer.

Authors:  R J Heald; N D Karanjia
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

9.  En bloc pelvic lymphadenectomy and sphincter preservation in the surgical management of rectal cancer.

Authors:  W E Enker; S J Pilipshen; M L Heilweil; M W Stearns; A J Janov; R E Hertz; S S Sternberg
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

10.  Laparoscopic lateral lymph node dissection in two fascial spaces for locally advanced lower rectal cancer.

Authors:  Hui-Hong Jiang; Hai-Long Liu; A-Jian Li; Wen-Chao Wang; Liang Lv; Jian Peng; Zhi-Hui Pan; Yi Chang; Mou-Bin Lin
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.